Pfizer pivots to cancer drugs for growth [MSN Money]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: MSN Money
Pfizer Pivots to Cancer Drugs for Growth © Monica Jorge for The Wall Street Journal The new lineup is projected to gerate $8. billion in sal this year, according to EvaluatePharma. For the first time, Pfizer in 09 expects oncology products to outsell the heart and other primary-care medicin the company was long known for. Pfizer is throwing in with other big drug compani trying to expand their footprint in cancer or gain a toehold, ev as many startups hunt for new therapi, too. Driving the attraction: new insights about the disease’s biology that have paved the way for discovery of treatmts, combined with major commercial pottial if those therapi reach the market. Load Error It is a significant transformation for Pfizer, whose sal of pills like Lipitor for high cholterol, and other drugs for common ailmts, powered its rise into one of the world’s biggt drugmakers. Now, the company is seeking a new round of growth by treating cancer. “At Pfizer, oncology is one of the core componts of
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- "FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about them so far. [CBS News]CBS News
- Telesis Bio Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Ulcerative Colitis Treatment Market Size Expected to Reach USD 14.77 Bn by 2033 [Yahoo! Finance]Yahoo! Finance
- Regenex Bio eyes FDA meeting to confirm pivotal DMD trial [Yahoo! Finance]Yahoo! Finance
- This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/9/24 - Form S-8
- 5/8/24 - Form 10-Q
- 5/1/24 - Form 4
- PFE's page on the SEC website